However, a panel consisting of chitotriosidase, Cyfra 21.1, Ca15.3, Ca125, and Ca19.9 showed better sensitivity and specificity at all follow-up times than any single biomarker in distinguishing IPF from non-IPF patients. The gene discussed is MUC16; the disease is idiopathic pulmonary fibrosis.